Showing results (261-270 of 336) with videos related to

Sort By:
Pageof 34
Journal of Ethnopharmacology|March 28, 2024
Human UDP-glucuronosyltransferase 1As catalyze aristolochic acid D O-glucuronidation to form a lesser nephrotoxic glucuronideDong-Zhu Tu, Pei-Qi Liu, Guang-Hao Zhu, et al.
Plos Biology|May 2, 2023
Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progressionBaohong Wu, Xuelan Chen, Xiangyu Pan, et al.
Gland Surgery|September 15, 2025
Association between preoperative body mass index and postoperative short-term outcomes in patients undergoing pancreaticoduodenectomy: a multicenter studyJudong Li, Ting Niu, Xiaowei Deng, et al.
American Journal of Cancer Research|November 18, 2024
The modified melphalan and busulfan-based regimen combined with maintenance therapy improved the survival of patients with refractory/relapsed AML after allogeneic transplantation: middle-term outcome of a multicenter trialShulian Chen, Xiaoyu Zhang, Ting Niu, et al.
Molecular Cancer Therapeutics|April 4, 2018
SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting MicrotubulesFang Wang, Li Zheng, Yuyao Yi, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 12, 2026
The role of KPNA3 in multiple myeloma: implications for targeting nuclear importHongmei Luo, Ziyue Mi, Jingcao Huang, et al.
International Journal of Cancer|July 4, 2025
Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observationsSiyao He, Jingjing Wen, Zhongqing Zou, et al.
BMC Cancer|May 7, 2025
Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myelomaLuqun Wang, Wei Yang, Yafei Wang, et al.
Journal of Medicinal Chemistry|April 3, 2019
Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous LeukemiaXue Yuan, Yong Chen, Wanhua Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2009
Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatinRui Z Bai, Yang Wu, Quan Liu, et al.
Pageof 34